日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Suppression of LTBP1 enhances the sensitivity of bladder cancer to cisplatin

抑制LTBP1可增强膀胱癌对顺铂的敏感性

Li, Zongyang; Yu, Yongbo; Liu, Fang; Wu, Yushu; Zang, Yunjiang; Ding, Yanhong; Zhang, Zhilei

Isavuconazole as an optimal treatment option for multiple pathogens induced severe pneumonia in immunocompromised hosts: a case series report

伊沙康唑作为治疗免疫功能低下宿主多种病原体诱发的严重肺炎的最佳选择:病例系列报告

Wang, Xinyin; You, Yanjing; Chen, Shuyang; Wang, Peiyu; Zeng, Shengyuan; Zhuang, Liying; Wang, Meng; Lai, Guoxiang; Yu, Zongyang; Yu, Guoqing; Wen, Wen

USP8-mediated PTK7 promotes PIK3CB-related pathway to accelerate the malignant progression of non-small cell lung cancer

USP8介导PTK7促进PIK3CB相关通路加速非小细胞肺癌恶性进展

Wencui Kong, Xuegang Feng, Zongyang Yu, Xingfeng Qi, Zhongquan Zhao

Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer

晚期非小细胞肺癌中免疫检查点抑制剂的再次应用

Lin, Gen; Wang, Zhijie; Chu, Qian; Hu, Yi; Huang, Dingzhi; Wang, Jun; Yang, Fan; Zhong, Wenzhao; Zhou, Chengzhi; Zhu, Bo; Ai, Xinghao; Cao, Baoshan; Cao, Yabing; Chen, Mingqiu; Chen, Xiaohui; Chu, Tianqing; Duan, Jianchun; Fan, Yun; Fang, Yong; Feng, Shuitu; Feng, Weineng; Guo, Hui; Han, Chengbo; He, Yong; Hong, Shaodong; Hu, Jie; Huang, Meijuan; Huang, Yan; Jiang, Da; Jiang, Kan; Jiang, Richeng; Jin, Bo; Jin, Shi; Li, Jisheng; Li, Min; Li, Ziming; Li, Chao; Lin, Jie; Liu, Anwen; Liu, Si-Yang Maggie; Yutao, Liu; Liu, Zhefeng; Liu, Zhe; Liu, Zhenhua; Liu, Zhentian; Liu, Zhigang; Lu, Yuping; Lv, Tangfeng; Ma, Zhiyong; Miao, Qian; Peng, Min; Pu, Xingxiang; Ren, Xiu Bao; Shan, Jianzhen; Shan, Jinlu; Shen, Peng; Shen, Bo; Shi, Meiqi; Song, Yong; Song, Zhengbo; Su, ChunXia; Sun, Jianguo; Tian, Panwen; Wang, Jinliang; Wang, Feng; Wang, Huijuan; Wang, Jialei; Wang, Qian; Wang, Wenxian; Wang, Yan; Wu, Lin; Wu, Fang; Xia, Yang; Xie, Congying; Xie, Conghua; Xin, Tao; Xiong, Jianping; Xu, Haipeng; Xu, Song; Xu, Yiquan; Xu, Bin; Xu, Chunwei; Yan, Xiaolong; Yang, Zhenzhou; Yao, Wenxiu; Yu, Yao; Feng, Ye; Yu, Zongyang; Yu, Yongfeng; Yue, Dongsheng; Zhang, Haibo; Zhang, HongMei; Zhang, Li; Zhang, Longfeng; Zhang, Qiuyu; Zhang, Tongmei; Zhang, Bicheng; Zhao, Jun; Zhao, Mingfang; Zheng, Xiaobin; Zhong, Qiaofeng; Zhou, Jin; Zhou, Penghui; Zhu, Zhengfei; Zou, Juntao; Zou, Zihua

Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer

非小细胞肺癌免疫治疗继发性耐药的临床定义

Huang, Dingzhi; Lin, Gen; Chu, Qian; Hu, Yi; Wang, Jun; Wang, Zhijie; Yang, Fan; Zhong, Wenzhao; Zhou, Chengzhi; Zhu, Bo; Ai, Xinghao; Cao, Baoshan; Cao, Yabing; Chen, Mingqiu; Chen, Xiaohui; Chu, Tianqing; Duan, Jianchun; Fan, Yun; Fang, Yong; Feng, Shuitu; Feng, Weineng; Guo, Hui; Han, Chengbo; He, Yong; Hong, Shaodong; Hu, Jie; Huang, Meijuan; Huang, Yan; Jiang, Da; Jiang, Kan; Jiang, Richeng; Jin, Bo; Jin, Shi; Li, Jisheng; Li, Min; Li, Ziming; Li, Chao; Lin, Jie; Liu, Anwen; Liu, Si-Yang Maggie; Liu, Yutao; Liu, Zhefeng; Liu, Zhe; Liu, Zhenhua; Liu, Zhentian; Liu, Zhigang; Lu, Yuping; Lv, Tangfeng; Ma, Zhiyong; Miao, Qian; Peng, Min; Pu, Xingxiang; Ren, Xiu Bao; Shan, Jianzhen; Shan, Jinlu; Shen, Peng; Shen, Bo; Shi, Meiqi; Song, Yong; Song, Zhengbo; Su, ChunXia; Sun, Jianguo; Tian, Panwen; Wang, Jinliang; Wang, Feng; Wang, Huijuan; Wang, Jialei; Wang, Qian; Wang, Wenxian; Wang, Yan; Wu, Lin; Wu, Fang; Xia, Yang; Xie, Congying; Xie, Conghua; Xin, Tao; Xiong, Jianping; Xu, Haipeng; Xu, Song; Xu, Yiquan; Xu, Bin; Xu, Chunwei; Yan, Xiaolong; Yang, Zhenzhou; Yao, Wenxiu; Yu, Yao; Feng, Ye; Yu, Zongyang; Yu, Yongfeng; Yue, Dongsheng; Zhang, Haibo; Zhang, HongMei; Zhang, Li; Zhang, Longfeng; Zhang, Qiuyu; Zhang, Tongmei; Zhang, Bicheng; Zhao, Jun; Zhao, Mingfang; Zheng, Xiaobin; Zhong, Fengqiao; Zhou, Jin; Zhou, Penghui; Zhu, Zhengfei; Zou, Juntao; Zou, Zihua

Silencing USP19 alleviates cigarette smoke extract-induced mitochondrial dysfunction in BEAS-2B cells by targeting FUNDC1

通过靶向 FUNDC1,沉默 USP19 可减轻香烟烟雾提取物引起的 BEAS-2B 细胞线粒体功能障碍

Yanjing You, Huijuan Wang, Qing Wang, Zongyang Yu, Zhongquan Zhao, Liying Zhuang, Shengyuan Zeng, Jinyang Zheng, Wen Wen

Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILK

沉默LncRNA CASC9通过MiR-542-3p/ILK抑制结直肠癌细胞的增殖和侵袭

Heping Zhang, Jingfang Wang, Taoyuan Yu, Jingmin Wang, Jun Lu, Zongyang Yu

CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway

miR-302e调控CXCL1通过抑制JAK-STAT信号通路影响结直肠癌细胞活力和迁移能力

Biyin Chen, Li Song, Xiuzhen Nie, Fangfeng Lin, Zongyang Yu, Wencui Kong, Xiaoyan Qi, Wenwu Wang

Hesperetin reverses P‑glycoprotein‑mediated cisplatin resistance in DDP‑resistant human lung cancer cells via modulation of the nuclear factor‑κB signaling pathway

橙皮素通过调节核因子 κB 信号通路逆转 DDP 耐药人肺癌细胞中 P 糖蛋白介导的顺铂耐药性

Wencui Kong, Xiaoming Ling, Ying Chen, Xiaoli Wu, Zhongquan Zhao, Wenwu Wang, Shuiliang Wang, Guoxiang Lai, Zongyang Yu

The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/ Stat 5/β- Catenin Signaling Pathway

ARL4C 在厄洛替尼耐药中的作用:激活 Jak2/Stat 5/β-Catenin 信号通路

Jinrong Liao, Zeng Chen, Zongyang Yu, Tao Huang, Dan Hu, Ying Su, Zhiyong He, Changyan Zou, Lurong Zhang, Xiandong Lin